With the creation of a new antibody library, HuCAL Gold, MorphoSys AG says it may have found a solution that will make its court battle with Cambridge Antibody Technology Group plc moot.

The companies have been squabbling in European and U.S. courts over whether MOR is infringing CAT's patents covering a method for obtaining antibodies to specific human self-antigens through the use of phage display libraries.